Cell and Gene Therapy Market Growth & Future Trends 2031
Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Cell Therapy and Gene Therapy), Service (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-commercial/R and D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), Transfection Reagents (Polymer-based Transfection Reagents, Lipid-based Transfection Reagents, Viral Transduction Enhancers, and Others), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
- Report Date : Jan 2026
- Report Code : TIPRE00020854
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 300
The Cell and Gene Therapy Market size is projected to reach US$ 25.78 billion by 2031 from US$ 5.30 billion in 2024. The market is expected to register a CAGR of 25.5% during 2025–2031.
Cell and Gene Therapy Market AnalysisThe cell and gene therapy market is experiencing robust growth due to rising chronic and genetic diseases, expanding funding and biotech investments, increased support from regulations, and technological innovations such as CRISPR and CAR-T. Partnerships among various players in the industry and their investment in more clinical programs speed up the process of getting advanced therapeutics out in the market.
Cell and Gene Therapy Market OverviewInnovative treatments target unmet needs across oncology, rare diseases, and personalized medicine. Advances in gene editing, scalable manufacturing technologies, and automated production systems thereby make the therapy less expensive and easier, and attract public and private investments. Researchers, through the collaboration of academic and industrial sectors, get their research done and increase the number of clinical trials in the pipeline. Positive regulatory regulations and quicker approval routes hasten the entrance of new therapies into the market. The worldwide knowledge of regenerative treatments is increasing, and the demand for curative treatment rather than traditional ones is driving wider acceptance and long-term growth of the industry.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell and Gene Therapy Market Drivers and OpportunitiesCustomize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Increasing Prevalence of Chronic and Genetic Diseases: The global increase in the incidence of cancer, autoimmune, and inherited genetic disorders is driving the need for advanced, targeted, and curative treatments, thus putting cell and gene therapies as an alternative to long-term disease management.
- Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing: The production of cell and gene therapy has become so complex that it is now a common practice for developers to outsource manufacturing to the specialized CDMOs, which leads to cost efficiency, scalability, regulatory compliance, and faster clinical and commercial timelines.
- Surging Regulatory Approvals and Commercialization: The use of accelerated regulatory pathways, orphan drug designations, and supportive approval frameworks allows for the quicker commercialization of cell and gene therapies, which raises market confidence, increases investment flow, and gives patients more access to innovative treatments.
Market Opportunities:
- Strategic Initiatives by Companies: Pharmaceutical and biotechnology companies are resorting to partnerships, acquisitions, and technology collaborations as a means of expanding their pipelines, bolstering manufacturing capabilities, and hastening the commercialization of cell and gene therapy innovations.
- Supportive Government Initiatives: The governments of different nations are using a variety of strategies, such as favorable policies, funding programs, tax incentives, and expedited regulatory pathways, thus improving patients’ accessibility to advanced therapeutic technologies.
- Rising Investments in Research and Development and Clinical Trials: The rising public and private investment in research and clinical trials is promoting the exploration, verification, and scaling of new cell and gene therapies, which is making treatments more effective.
The cell and gene therapy market is segmented into distinct categories to provide a clearer understanding of its operations, growth potential, and current trends. Below is the standard segmentation approach used in industry reports:
By Type:
- Cell Therapy: Cell therapy demand is driven by increasing adoption in oncology and regenerative medicine, proven clinical outcomes, expanding stem cell research, and continuous advancements in cell processing and manufacturing technologies.
- Gene Therapy: Gene therapy adoption is supported by progress in gene editing tools, rising approvals for rare disease treatments, strong clinical pipelines, and growing demand for long-term or curative therapeutic solutions.
By Service:
- Process Development
- cGMP Manufacturing
- Regulatory Services
- Bioassay Services
By Scale:
- Pre-commercial/R and D Manufacturing
- Commercial Scale Manufacturing
By Service Providers:
- CDMOs
- CMOs
By Transfection Reagents:
- Polymer-based Transfection Reagents
- Lipid-based Transfection Reagents
- Viral Transduction Enhancers
- Others
By End User:
- Contract Research Organizations
- Pharmaceutical and Biopharmaceutical Companies
- Academic and Research Institutes
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
Market Report Scope
Cell and Gene Therapy Market Share Analysis by GeographyAsia Pacific is expected to grow the fastest in the next few years. Emerging markets in South America, the Middle East, and Africa have untapped opportunities for cell and gene therapy providers to expand.
The growth of the cell and gene therapy market varies across regions due to factors such as rising disease burden, government funding, biotechnology innovation, and expanding healthcare infrastructure. Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds a significant portion of the global market
- Key Drivers: Advanced R&D, strong regulatory support, and extensive clinical pipelines fueling the adoption of novel therapies.
- Trends: Rapid expansion of specialized clinical trials and manufacturing hubs.
2. Europe
- Market Share: Substantial market share
- Key Drivers: Collaborative EU funding, integrated regulatory pathways, and aging populations increasing demand for regenerative and rare‑disease treatments.
- Trends: Harmonization of approvals across countries boosting cross‑border therapy development.
3. Asia Pacific
- Market Share: Fastest-growing region with a rising market share every year
- Key Drivers: Rising healthcare spending, supportive government initiatives, and increasing clinical activity in China, Japan, and India.
- Trends: Domestic innovation and pro‑innovation policies.
4. South and Central America
- Market Share: Growing market with steady progress
- Key Drivers: Expanding healthcare access, rising clinical research, and partnerships improving local therapy adoption.
- Trends: Increasing public‑private collaborations enhance regional biotech infrastructure.
5. Middle East and Africa
- Market Share: Although small, it is growing quickly
- Key Drivers: Rising healthcare modernization, government investment, and expanding treatment centers, despite limited current infrastructure.
- Trends: Strategic partnerships with global biotech firms accelerate capability building.
High Market Density and Competition
Competition is strong due to the presence of established players such as Lonza Group AG and WuXi AppTec Co Ltd. Regional and niche providers add to the competitive landscape across regions.
The high level of competition urges companies to stand out by offering:
- Advanced Products and Services
- Product Approvals
- Compliance with Regulatory Guidelines
Opportunities and Strategic Moves
- Expanding manufacturing capacities and advanced technologies such as CRISPR, AI, and automated bioprocessing boost scalability, lowering costs and broadening global access.
- Companies pursue partnerships, acquisitions, and geographic expansion to accelerate R&D, diversify pipelines, and integrate end‑to‑end production for competitive advantage.
- Novartis AG
- CRISPR Therapeutics AG
- Bluebird Bio, Inc.
- Oxford Biomedica plc
- AGC Biologics Inc.
- Evotec SE
- Samsung Biologics Co., Ltd.
- Rocket Pharmaceuticals
- Krystal Biotech, Inc.
- Adaptimmune Therapeutics.
- In October 2025, Lonza Group AG broadened its suite of cell and gene therapy manufacturing solutions with the launch of two new products: TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium. The additions are aimed at enhancing the scalability and consistency of advanced therapy production under Good Manufacturing Practice (GMP) conditions.
- In December 2025, the US Food and Drug Administration (FDA) approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS). Waskyra is indicated for paediatric patients six months and older and adults with WAS. The approval was granted to Fondazione Telethon ETS, making this the first approved cell and gene therapy product from a non-profit applicant.
The "Cell and Gene Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Cell and Gene Therapy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Cell and Gene Therapy Market trends, as well as market dynamics such as drivers, restraints, and opportunities
- Detailed PEST and SWOT analysis
- Cell and Gene Therapy Market analysis covering key trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell and gene therapy Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Cell and Gene Therapy Catapult, Lonza Group AG, WuXi AppTec Co Ltd, Takara Bio Inc., FUJIFILM Holdings Corp, F. Hoffmann-La Roche Ltd, and Catalent Inc. are among the key players operating in the cell and gene therapy market.
The cell and gene therapy market is estimated to register a CAGR of 25.5% during the forecast period.
The increasing prevalence of chronic and genetic diseases, the rapid popularity of outsourcing cell and gene therapy manufacturing, and surging regulatory approvals and commercialization are noteworthy factors contributing to market growth.
North America dominated the market in 2024.
The cell and gene therapy market is projected to reach a value of US$ 25.78 billion by 2031.
1. Executive Summary
1.1 Analyst Market Outlook
1.2 Market Attractiveness
2. Cell and Gene Therapy Market Landscape
2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
2.3.1 List of Manufacturers/Suppliers
2.3.2 List of Potential Customers (Upto 50)
2.4 PEST Analysis
2.5 Impact of Artificial Intelligence (AI)
2.6 Cell Therapy or Technology Roadmap
2.7 Sustainability and ESG Trends
2.8 Patent Analysis
2.9 Regulatory Framework
3. Competitive Landscape
3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2024 – By Key Players
3.3 Market Concentration
4. Cell and Gene Therapy Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic and Genetic Diseases
4.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surging Regulatory Approvals and Commercialization
4.2 Market Restraints
4.2.1 High Costs of Development and Treatment
4.2.2 Stringent Regulatory Challenges
4.2.3 Shortage Of Skilled Professionals and Infrastructure
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Companies
4.3.2 Supportive Government Initiatives
4.3.3 Rising Investments in Research & Development and Clinical Trials
4.4 Future Trends
4.4.1 Integration of AI and Automation
4.4.2 Development of Next-Generation Gene Editing Tools
4.4.3 Rise of Allogeneic and Off-The-Shelf Therapies
4.5 Impact of Drivers and Restraints
5. Cell and Gene Therapy Market – Global Market Analysis
5.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
5.2 Cell and Gene Therapy Market Forecast and Analysis
6. Cell and Gene Therapy Market Revenue Analysis –Type
6.1 Cell and Gene Therapy Market Forecasts and Analysis by Type
6.1.1 Cell Therapy
6.1.1.1 Overview
6.1.1.2 Cell Therapy: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
6.1.2 Gene Therapy
6.1.2.1 Overview
6.1.2.2 Gene Therapy: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7. Cell and Gene Therapy Market Revenue Analysis –Service
7.1 Cell and Gene Therapy Market Forecasts and Analysis by Service
7.1.1 Process Development
7.1.1.1 Overview
7.1.1.2 Process Development: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.2 cGMP Manufacturing
7.1.2.1 Overview
7.1.2.2 cGMP Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.3 Regulatory Services
7.1.3.1 Overview
7.1.3.2 Regulatory Services: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
7.1.4 Bioassay Services
7.1.4.1 Overview
7.1.4.2 Bioassay Services: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
8. Cell and Gene Therapy Market Revenue Analysis – Scale
8.1 Cell and Gene Therapy Market Forecasts and Analysis by Scale
8.1.1 Pre-commercial/R and D Manufacturing
8.1.1.1 Overview
8.1.1.2 Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
8.1.2 Commercial Scale Manufacturing
8.1.2.1 Overview
8.1.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
9. Cell and Gene Therapy Market Revenue Analysis –Service Providers
9.1 Cell and Gene Therapy Market Forecasts and Analysis by Service Providers
9.1.1 CDMOs
9.1.1.1 Overview
9.1.1.2 CDMOs: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
9.1.2 CMOs
9.1.2.1 Overview
9.1.2.2 CMOs: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10. Cell and Gene Therapy Market Revenue Analysis – Transfection Reagents
10.1 Cell and Gene Therapy Market Forecasts and Analysis by Transfection Reagents
10.1.1 Polymer-based Transfection Reagents
10.1.1.1 Overview
10.1.1.2 Polymer-based Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.2 Lipid-based Transfection Reagents
10.1.2.1 Overview
10.1.2.2 Lipid-based Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.3 Viral Transduction Enhancers
10.1.3.1 Overview
10.1.3.2 Viral Transduction Enhancers: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
10.1.4 Other Transfection Reagents
10.1.4.1 Overview
10.1.4.2 Other Transfection Reagents: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11. Cell and Gene Therapy Market Revenue Analysis – By End User
11.1 Cell and Gene Therapy Market Forecasts and Analysis by End User
11.1.1 Contract Research Organizations
11.1.1.1 Overview
11.1.1.2 Contract Research Organizations: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11.1.2 Pharmaceutical and Biopharmaceutical Companies
11.1.2.1 Overview
11.1.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
11.1. Academic and Research Institutes
11.1.3.1 Overview
11.1.3.2 Academic and Research Institutes: Cell and Gene Therapy Market –Revenue, 2021–2031 (US$ Million)
12. Cell and Gene Therapy Market – Geographical Analysis
12.1 North America
12.1.1 North America Cell and Gene Therapy Market Overview
12.1.2 North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.3 North America: Cell and Gene Therapy Market– By Segmentation
12.1.3.1 Type
12.1.3.2 Cell Therapy For Type
12.1.3.3 Gene Therapy For Type
12.1.3.4 Service
12.1.3.5 Scale
12.1.3.6 Service Providers
12.1.3.7 Transfection Reagents
12.1.3.8 End User
12.1.4 North America: Cell and Gene Therapy Market Breakdown by Countries
12.1.4.1 United States Market
12.1.4.1.1 United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.1.2 United States: Cell and Gene Therapy Market– By Segmentation
12.1.4.1.2.1 Type
12.1.4.1.2.2 Cell Therapy For Type
12.1.4.1.2.3 Gene Therapy For Type
12.1.4.1.2.4 Service
12.1.4.1.2.5 Scale
12.1.4.1.2.6 Service Providers
12.1.4.1.2.7 Transfection Reagents
12.1.4.1.2.8 End User
12.1.4.2 Canada Market
12.1.4.2.1 Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.2.2 Canada: Cell and Gene Therapy Market– By Segmentation
12.1.4.2.2.1 Type
12.1.4.2.2.2 Cell Therapy For Type
12.1.4.2.2.3 Gene Therapy For Type
12.1.4.2.2.4 Service
12.1.4.2.2.5 Scale
12.1.4.2.2.6 Service Providers
12.1.4.2.2.7 Transfection Reagents
12.1.4.2.2.8 End User
12.1.4.3 Mexico Market
12.1.4.3.1 Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.1.4.3.2 Mexico: Cell and Gene Therapy Market– By Segmentation
12.1.4.3.2.1 Type
12.1.4.3.2.2 Cell Therapy For Type
12.1.4.3.2.3 Gene Therapy For Type
12.1.4.3.2.4 Service
12.1.4.3.2.5 Scale
12.1.4.3.2.6 Service Providers
12.1.4.3.2.7 Transfection Reagents
12.1.4.3.2.8 End User
12.2 Europe
12.2.1 Europe Cell and Gene Therapy Market Overview
12.2.2 Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.3 Europe: Cell and Gene Therapy Market– By Segmentation
12.2.3.1 Type
12.2.3.2 Cell Therapy For Type
12.2.3.3 Gene Therapy For Type
12.2.3.4 Service
12.2.3.5 Scale
12.2.3.6 Service Providers
12.2.3.7 Transfection Reagents
12.2.3.8 End User
12.2.4 Europe: Cell and Gene Therapy Market Breakdown by Countries
12.2.4.1 United Kingdom Market
12.2.4.1.1 United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.1.2 United Kingdom: Cell and Gene Therapy Market– By Segmentation
12.2.4.1.2.1 Type
12.2.4.1.2.2 Cell Therapy For Type
12.2.4.1.2.3 Gene Therapy For Type
12.2.4.1.2.4 Service
12.2.4.1.2.5 Scale
12.2.4.1.2.6 Service Providers
12.2.4.1.2.7 Transfection Reagents
12.2.4.1.2.8 End User
12.2.4.2 Germany Market
12.2.4.2.1 Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.2.2 Germany: Cell and Gene Therapy Market– By Segmentation
12.2.4.2.2.1 Type
12.2.4.2.2.2 Cell Therapy For Type
12.2.4.2.2.3 Gene Therapy For Type
12.2.4.2.2.4 Service
12.2.4.2.2.5 Scale
12.2.4.2.2.6 Service Providers
12.2.4.2.2.7 Transfection Reagents
12.2.4.2.2.8 End User
12.2.4.3 France Market
12.2.4.3.1 France: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.3.2 France: Cell and Gene Therapy Market– By Segmentation
12.2.4.3.2.1 Type
12.2.4.3.2.2 Cell Therapy For Type
12.2.4.3.2.3 Gene Therapy For Type
12.2.4.3.2.4 Service
12.2.4.3.2.5 Scale
12.2.4.3.2.6 Service Providers
12.2.4.3.2.7 Transfection Reagents
12.2.4.3.2.8 End User
12.2.4.4 Italy Market
12.2.4.4.1 Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.4.2 Italy: Cell and Gene Therapy Market– By Segmentation
12.2.4.4.2.1 Type
12.2.4.4.2.2 Cell Therapy For Type
12.2.4.4.2.3 Gene Therapy For Type
12.2.4.4.2.4 Service
12.2.4.4.2.5 Scale
12.2.4.4.2.6 Service Providers
12.2.4.4.2.7 Transfection Reagents
12.2.4.4.2.8 End User
12.2.4.5 Spain Market
12.2.4.5.1 Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.5.2 Spain: Cell and Gene Therapy Market– By Segmentation
12.2.4.5.2.1 Type
12.2.4.5.2.2 Cell Therapy For Type
12.2.4.5.2.3 Gene Therapy For Type
12.2.4.5.2.4 Service
12.2.4.5.2.5 Scale
12.2.4.5.2.6 Service Providers
12.2.4.5.2.7 Transfection Reagents
12.2.4.5.2.8 End User
12.2.4.6 Rest of Europe Market
12.2.4.6.1 Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.2.4.6.2 Rest of Europe: Cell and Gene Therapy Market– By Segmentation
12.2.4.6.2.1 Type
12.2.4.6.2.2 Cell Therapy For Type
12.2.4.6.2.3 Gene Therapy For Type
12.2.4.6.2.4 Service
12.2.4.6.2.5 Scale
12.2.4.6.2.6 Service Providers
12.2.4.6.2.7 Transfection Reagents
12.2.4.6.2.8 End User
12.3 Asia Pacific
12.3.1 Asia Pacific Cell and Gene Therapy Market Overview
12.3.2 Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.3 Asia Pacific: Cell and Gene Therapy Market– By Segmentation
12.3.3.1 Type
12.3.3.2 Cell Therapy For Type
12.3.3.3 Gene Therapy For Type
12.3.3.4 Service
12.3.3.5 Scale
12.3.3.6 Service Providers
12.3.3.7 Transfection Reagents
12.3.3.8 End User
12.3.4 Asia Pacific: Cell and Gene Therapy Market Breakdown by Countries
12.3.4.1 China Market
12.3.4.1.1 China: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.1.2 China: Cell and Gene Therapy Market– By Segmentation
12.3.4.1.2.1 Type
12.3.4.1.2.2 Cell Therapy For Type
12.3.4.1.2.3 Gene Therapy For Type
12.3.4.1.2.4 Service
12.3.4.1.2.5 Scale
12.3.4.1.2.6 Service Providers
12.3.4.1.2.7 Transfection Reagents
12.3.4.1.2.8 End User
12.3.4.2 Japan Market
12.3.4.2.1 Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.2.2 Japan: Cell and Gene Therapy Market– By Segmentation
12.3.4.2.2.1 Type
12.3.4.2.2.2 Cell Therapy For Type
12.3.4.2.2.3 Gene Therapy For Type
12.3.4.2.2.4 Service
12.3.4.2.2.5 Scale
12.3.4.2.2.6 Service Providers
12.3.4.2.2.7 Transfection Reagents
12.3.4.2.2.8 End User
12.3.4.3 India Market
12.3.4.3.1 India: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.3.2 India: Cell and Gene Therapy Market– By Segmentation
12.3.4.3.2.1 Type
12.3.4.3.2.2 Cell Therapy For Type
12.3.4.3.2.3 Gene Therapy For Type
12.3.4.3.2.4 Service
12.3.4.3.2.5 Scale
12.3.4.3.2.6 Service Providers
12.3.4.3.2.7 Transfection Reagents
12.3.4.3.2.8 End User
12.3.4.4 Australia Market
12.3.4.4.1 Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.4.2 Australia: Cell and Gene Therapy Market– By Segmentation
12.3.4.4.2.1 Type
12.3.4.4.2.2 Cell Therapy For Type
12.3.4.4.2.3 Gene Therapy For Type
12.3.4.4.2.4 Service
12.3.4.4.2.5 Scale
12.3.4.4.2.6 Service Providers
12.3.4.4.2.7 Transfection Reagents
12.3.4.4.2.8 End User
12.3.4.5 South Korea Market
12.3.4.5.1 South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.5.2 South Korea: Cell and Gene Therapy Market– By Segmentation
12.3.4.5.2.1 Type
12.3.4.5.2.2 Cell Therapy For Type
12.3.4.5.2.3 Gene Therapy For Type
12.3.4.5.2.4 Service
12.3.4.5.2.5 Scale
12.3.4.5.2.6 Service Providers
12.3.4.5.2.7 Transfection Reagents
12.3.4.5.2.8 End User
12.3.4.6 Rest of APAC Market
12.3.4.6.1 Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.3.4.6.2 Rest of APAC: Cell and Gene Therapy Market– By Segmentation
12.3.4.6.2.1 Type
12.3.4.6.2.2 Cell Therapy For Type
12.3.4.6.2.3 Gene Therapy For Type
12.3.4.6.2.4 Service
12.3.4.6.2.5 Scale
12.3.4.6.2.6 Service Providers
12.3.4.6.2.7 Transfection Reagents
12.3.4.6.2.8 End User
12.4 Middle East and Africa
12.4.1 Middle East and Africa Cell and Gene Therapy Market Overview
12.4.2 Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.3 Middle East and Africa: Cell and Gene Therapy Market– By Segmentation
12.4.3.1 Type
12.4.3.2 Cell Therapy For Type
12.4.3.3 Gene Therapy For Type
12.4.3.4 Service
12.4.3.5 Scale
12.4.3.6 Service Providers
12.4.3.7 Transfection Reagents
12.4.3.8 End User
12.4.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown by Countries
12.4.4.1 Saudi Arabia Market
12.4.4.1.1 Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.1.2 Saudi Arabia: Cell and Gene Therapy Market– By Segmentation
12.4.4.1.2.1 Type
12.4.4.1.2.2 Cell Therapy For Type
12.4.4.1.2.3 Gene Therapy For Type
12.4.4.1.2.4 Service
12.4.4.1.2.5 Scale
12.4.4.1.2.6 Service Providers
12.4.4.1.2.7 Transfection Reagents
12.4.4.1.2.8 End User
12.4.4.2 South Africa Market
12.4.4.2.1 South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.2.2 South Africa: Cell and Gene Therapy Market– By Segmentation
12.4.4.2.2.1 Type
12.4.4.2.2.2 Cell Therapy For Type
12.4.4.2.2.3 Gene Therapy For Type
12.4.4.2.2.4 Service
12.4.4.2.2.5 Scale
12.4.4.2.2.6 Service Providers
12.4.4.2.2.7 Transfection Reagents
12.4.4.2.2.8 End User
12.4.4.3 United Arab Emirates Market
12.4.4.3.1 United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.3.2 United Arab Emirates: Cell and Gene Therapy Market– By Segmentation
12.4.4.3.2.1 Type
12.4.4.3.2.2 Cell Therapy For Type
12.4.4.3.2.3 Gene Therapy For Type
12.4.4.3.2.4 Service
12.4.4.3.2.5 Scale
12.4.4.3.2.6 Service Providers
12.4.4.3.2.7 Transfection Reagents
12.4.4.3.2.8 End User
12.4.4.4 Rest of Middle East and Africa Market
12.4.4.4.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.4.4.4.2 Rest of Middle East and Africa: Cell and Gene Therapy Market– By Segmentation
12.4.4.4.2.1 Type
12.4.4.4.2.2 Cell Therapy For Type
12.4.4.4.2.3 Gene Therapy For Type
12.4.4.4.2.4 Service
12.4.4.4.2.5 Scale
12.4.4.4.2.6 Service Providers
12.4.4.4.2.7 Transfection Reagents
12.4.4.4.2.8 End User
12.5 South and Central America
12.5.1 South and Central America Cell and Gene Therapy Market Overview
12.5.2 South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.3 South and Central America: Cell and Gene Therapy Market– By Segmentation
12.5.3.1 Type
12.5.3.2 Cell Therapy For Type
12.5.3.3 Gene Therapy For Type
12.5.3.4 Service
12.5.3.5 Scale
12.5.3.6 Service Providers
12.5.3.7 Transfection Reagents
12.5.3.8 End User
12.5.4 South and Central America: Cell and Gene Therapy Market Breakdown by Countries
12.5.4.1 Brazil Market
12.5.4.1.1 Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.1.2 Brazil: Cell and Gene Therapy Market– By Segmentation
12.5.4.1.2.1 Type
12.5.4.1.2.2 Cell Therapy For Type
12.5.4.1.2.3 Gene Therapy For Type
12.5.4.1.2.4 Service
12.5.4.1.2.5 Scale
12.5.4.1.2.6 Service Providers
12.5.4.1.2.7 Transfection Reagents
12.5.4.1.2.8 End User
12.5.4.2 Argentina Market
12.5.4.2.1 Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.2.2 Argentina: Cell and Gene Therapy Market– By Segmentation
12.5.4.2.2.1 Type
12.5.4.2.2.2 Cell Therapy For Type
12.5.4.2.2.3 Gene Therapy For Type
12.5.4.2.2.4 Service
12.5.4.2.2.5 Scale
12.5.4.2.2.6 Service Providers
12.5.4.2.2.7 Transfection Reagents
12.5.4.2.2.8 End User
12.5.4.3 Rest of South and Central America Market
12.5.4.3.1 Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
12.5.4.3.2 Rest of South and Central America: Cell and Gene Therapy Market– By Segmentation
12.5.4.3.2.1 Type
12.5.4.3.2.2 Cell Therapy For Type
12.5.4.3.2.3 Gene Therapy For Type
12.5.4.3.2.4 Service
12.5.4.3.2.5 Scale
12.5.4.3.2.6 Service Providers
12.5.4.3.2.7 Transfection Reagents
12.5.4.3.2.8 End User
13. Cell and Gene Therapy Market Industry Landscape
14. Cell and Gene Therapy Market – Key Company Profiles
14.1 CRISPR Therapeutics
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Cell Therapys and Gene Therapy
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Horizon Discovery Group plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Cell Therapys and Gene Therapy
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Cell Therapys and Gene Therapy
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Cell Therapys and Gene Therapy
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Integrated DNA Technologies Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Cell Therapys and Gene Therapy
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 QIAGEN NV
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Cell Therapys and Gene Therapy
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Takara Bio Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Cell Therapys and Gene Therapy
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Synthego Holdings LLC
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Cell Therapys and Gene Therapy
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GenScript Biotech Corporation
14.9.1 Key Facts
14.12.2 Business Description
14.12.3 Cell Therapys and Gene Therapy
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.9.6 Key Developments
14.10 Editas Medicine Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Cell Therapys and Gene Therapy
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary
15.2 List of Tables
15.3 List of Figures
15.4 Research Methodology and Approach
15.4.1 Secondary Research
15.4.2 Primary Research
15.4.3 Market Estimation Approach
15.4.3.1 Supply Side Analysis
15.4.3.2 Demand Side Analysis
15.4.4 Research Assumptions and Limitations
15.4.5 Currency Conversion
15.5 About The Insight Partners
15.6 Market Intelligence Cloud
List of TablesTable 1. Cell and Gene Therapy Market Segmentation
Table 2. List of Service Providers
Table 3. List of Potential Customers
Table 4. List of Patents and Description
Table 5. List of Regulatory Bodies and Organizations
Table 6. Ease of Doing Business: Key Country Rankings
Table 7. Market Share Analysis, 2024 – By Key Players
Table 8. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million)
Table 6. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million)
Table 7. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Type
Table 8. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Type
Table 9. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 10. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 11. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 12. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 13. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 14. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 15. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 16. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 17. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 18. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 19. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 20. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 21. Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 22. Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 23. North America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 24. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 25. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 26. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 27. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 28. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 29. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 30. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 31. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 32. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 33. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 34. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 35. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 36. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 37. North America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 38. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 39. North America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 40. North America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 41. United States: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 42. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 43. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 44. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 45. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 46. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 47. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 48. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 49. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 50. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 51. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 52. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 53. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 54. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 55. United States: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 56. United States: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 57. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 58. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 59. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 60. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 61. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 62. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 63. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 64. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 65. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 66. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 67. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 68. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 69. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 70. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 71. Canada: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 72. Canada: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 73. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 74. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 75. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 76. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 77. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 78. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 79. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 80. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 81. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 82. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 83. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 84. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 85. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 86. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 87. Mexico: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 88. Mexico: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 89. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 90. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 91. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 92. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 93. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 94. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 95. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 96. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 97. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 98. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 99. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 100. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 101. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 102. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 103. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 104. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 105. Europe: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 106. Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 107. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 108. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 109. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 110. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 111. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 112. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 113. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 114. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 115. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 116. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 117. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 118. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 119. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 120. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 121. United Kingdom: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 122. United Kingdom: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 123. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 124. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 125. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 126. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 127. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 128. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 129. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 130. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 131. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 132. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 133. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 134. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 135. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 136. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 137. Germany: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 138. Germany: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 139. France: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 140. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 141. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 142. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 143. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 144. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 145. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 146. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 147. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 148. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 149. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 150. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 151. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 152. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 153. France: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 154. France: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 155. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 156. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 157. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 158. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 159. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 160. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 161. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 162. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 163. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 164. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 165. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 166. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 167. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 168. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 169. Italy: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 170. Italy: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 171. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 172. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 173. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 174. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 175. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 176. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 177. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 178. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 179. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 180. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 181. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 182. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 183. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 184. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 185. Spain: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 186. Spain: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 187. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 188. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 189. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 190. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 191. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 192. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 193. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 194. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 195. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 196. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 197. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 198. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 199. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 200. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 201. Rest of Europe: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 202. Rest of Europe: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 203. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 204. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 205. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 206. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 207. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 208. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 209. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 210. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 211. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 212. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 213. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 214. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 215. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 216. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 217. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 218. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 219. Asia Pacific: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 220. Asia Pacific: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 221. China: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 222. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 223. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 224. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 225. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 226. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 227. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 228. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 229. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 230. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 231. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 232. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 233. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 234. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 235. China: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 236. China: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 237. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 238. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 239. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 240. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 241. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 242. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 243. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 244. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 245. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 246. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 247. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 248. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 249. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 250. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 251. Japan: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 252. Japan: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 253. India: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 254. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 255. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 256. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 257. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 258. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 259. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 260. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 261. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 262. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 263. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 264. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 265. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 266. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 267. India: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 268. India: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 269. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 270. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 271. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 272. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 273. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 274. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 275. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 276. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 277. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 278. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 279. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 280. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 281. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 282. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 283. Australia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 284. Australia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 285. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 286. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 287. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 288. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 289. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 290. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 291. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 292. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 293. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 294. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 295. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 296. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 297. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 298. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 299. South Korea: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 300. South Korea: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 301. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 302. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 303. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 304. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 305. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 306. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 307. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 308. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 309. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 310. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 311. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 312. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 313. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 314. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 315. Rest of APAC: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 316. Rest of APAC: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 317. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 318. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 319. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 320. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 321. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 322. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 323. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 324. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 325. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 326. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 327. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 328. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 329. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 330. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 331. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 332. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 333. Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 334. Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 335. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 336. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 337. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 338. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 339. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 340. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 341. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 342. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 343. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 344. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 345. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 346. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 347. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 348. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 349. Saudi Arabia: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 350. Saudi Arabia: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 351. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 352. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 353. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 354. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 355. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 356. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 357. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 358. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 359. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 360. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 361. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 362. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 363. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 364. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 365. South Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 366. South Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 367. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 368. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 369. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 370. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 371. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 372. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 373. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 374. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 375. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 376. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 377. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 378. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 379. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 380. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 381. United Arab Emirates: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 382. United Arab Emirates: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 383. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 384. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 385. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 386. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 387. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 388. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 389. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 390. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 391. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 392. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 393. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 394. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 395. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 396. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 397. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 398. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 399. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 400. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 401. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 402. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 403. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 404. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 405. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 406. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 407. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 408. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 409. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 410. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 411. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 412. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 413. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 414. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 415. South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 416. South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 417. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 418. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 419. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 420. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 421. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 422. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 423. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 424. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 425. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 426. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 427. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 428. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 429. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 430. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 431. Brazil: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 432. Brazil: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 433. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 434. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 435. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 436. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 437. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 438. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 439. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 440. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 441. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 442. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 443. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 444. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 445. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 446. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 447. Argentina: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 448. Argentina: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 449. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 450. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 451. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Cell Therapy for Type
Table 452. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Cell Therapy for Type
Table 453. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Gene Therapy for Type
Table 454. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Gene Therapy for Type
Table 455. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service
Table 456. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service
Table 457. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Scale
Table 458. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Scale
Table 459. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Service Providers
Table 460. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Service Providers
Table 461. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by Transfection Reagents
Table 462. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by Transfection Reagents
Table 463. Rest of South and Central America: Cell and Gene Therapy Market – Revenue, 2021–2024(US$ Million) – by End User
Table 464. Rest of South and Central America: Cell and Gene Therapy Market – Revenue Forecast, 2025–2031(US$ Million) – by End User
Table 465. List of Additional Companies Analyzed
Table 466. Glossary – Cell and Gene Therapy Market
List of FiguresFigure 1. Cell and Gene Therapy Market – Value Chain Analysis
Figure 2. Pest Analysis
Figure 3. Cell and Gene Therapy Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
Figure 6. Cell and Gene Therapy Market Share (%) – by Type (2024 and 2031)
Figure 7. Cell Therapy: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 8. Gene Therapy: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 9. Cell and Gene Therapy Market Share (%) – by Service (2024 and 2031)
Figure 10. Process Development: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 11. cGMP Manufacturing: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 12. Regulatory Services: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 13. Bioassay Services: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 14. Cell and Gene Therapy Market Share (%) – by Scale (2024 and 2031)
Figure 15. Pre-commercial/R and D Manufacturing: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 16. Commercial Scale Manufacturing: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 17. Cell and Gene Therapy Market Share (%) – by Service Providers (2024 and 2031)
Figure 18. CDMOs: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 19. CMOs: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 20. Cell and Gene Therapy Market Share (%) – by Transfection Reagents (2024 and 2031)
Figure 21. Polymer-based Transfection Reagents: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 22. Lipid-based Transfection Reagents: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 23. Viral Transduction Enhancers: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 24. Other Transfection Reagents: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 25. Cell and Gene Therapy Market Share (%) – by End User (2024 and 2031)
Figure 26. Contract Research Organizations: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 27. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 28. Academic and Research Institutes: Cell and Gene Therapy Market –Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 29. Cell and Gene Therapy Market Breakdown by Geography, 2024 and 2031
Figure 30. North America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 31. North America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 32. United States: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 33. Canada: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 34. Mexico: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 35. Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 36. Europe: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 37. United Kingdom: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 38. Germany: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 39. France: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 40. Italy: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 41. Spain: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 42. Rest of Europe: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 43. Asia Pacific: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 44. Asia Pacific: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 45. China: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 46. Japan: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 47. India: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 48. Australia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 49. South Korea: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 50. Rest of APAC: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 51. Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 52. Middle East and Africa: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 54. South Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 55. United Arab Emirates: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 56. Rest of Middle East and Africa: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 57. South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 58. South and Central America: Cell and Gene Therapy Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 59. Brazil: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 60. Argentina: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 61. Rest of South and Central America: Cell and Gene Therapy Market Revenue and Forecasts, 2021–2031 (US$ Million)
Figure 62. Bottom–Up Approach and Top–Down Approach
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Jan 2026
RT-PCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Jan 2026
dPCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Jan 2026
Oscillometry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Device and Accessories), Technology (Impulse Oscillometry, Forced Oscillation Technique, and Hybrid Oscillometry Devices), Application (Asthma, COPD, and Others), End User (Hospitals, Diagnostic Laboratories, and Others)
Jan 2026
Prenatal Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type (Noninvasive and Invasive), Disease (Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others), End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Jan 2026
Joint Resurfacing Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Knee, Hip, Shoulder, Ankle, and Others), Material (Metal, Ceramic, and Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)
Jan 2026
Embolization Plugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Jan 2026
Aesthetic Exosomes Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human-derived, Animal-derived, and Plant-derived), Route of Administration (Topical and Injectable), Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), and End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Jan 2026
Carrier Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Other Medical Conditions), End User (Hospital-Based Laboratories, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Get Free Sample For